Clean quarterly read on $RIVN — let's break down what matters structurally.
Deliveries hit 19,248, a company record. That's the headline, but here's the teaching moment: delivery growth alone doesn't confirm a bullish setup unless it translates into margin improvement and cash efficiency. Right now, we're seeing top-line expansion — revenue up 38% to $2.16B, beating the $1.99B estimate — but the structure underneath is still bleeding.
Loss per share came in at $0.48 vs $0.62 expected. That's a beat, but it's still a loss. More importantly, free cash flow was -$1.12B in Q3. That's the invalidation level for any long-term bull thesis: if cash burn doesn't compress meaningfully into 2025, this rally is just a relief bounce, not a structural shift.
Management raised 2026 delivery guidance to 67,000–70,000. That's forward-looking confidence, and the market liked it — stock popped 4.3% at the open to $11.95. But here's the setup: this move is sentiment-driven, not fundamentally confirmed. You're buying optimism on future scale, not current profitability.
The trade idea: if you're long here, your confirmation is sequential improvement in cash burn and gross margin over the next two quarters. Your invalidation is another quarter of -$1B+ free cash flow or delivery misses. If that happens, this rally fails and you're back below $10.
This is a momentum play on guidance, not a value setup. Know the difference — and trade accordingly.
Deliveries hit 19,248, a company record. That's the headline, but here's the teaching moment: delivery growth alone doesn't confirm a bullish setup unless it translates into margin improvement and cash efficiency. Right now, we're seeing top-line expansion — revenue up 38% to $2.16B, beating the $1.99B estimate — but the structure underneath is still bleeding.
Loss per share came in at $0.48 vs $0.62 expected. That's a beat, but it's still a loss. More importantly, free cash flow was -$1.12B in Q3. That's the invalidation level for any long-term bull thesis: if cash burn doesn't compress meaningfully into 2025, this rally is just a relief bounce, not a structural shift.
Management raised 2026 delivery guidance to 67,000–70,000. That's forward-looking confidence, and the market liked it — stock popped 4.3% at the open to $11.95. But here's the setup: this move is sentiment-driven, not fundamentally confirmed. You're buying optimism on future scale, not current profitability.
The trade idea: if you're long here, your confirmation is sequential improvement in cash burn and gross margin over the next two quarters. Your invalidation is another quarter of -$1B+ free cash flow or delivery misses. If that happens, this rally fails and you're back below $10.
This is a momentum play on guidance, not a value setup. Know the difference — and trade accordingly.